Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | CFTR | P13569 | 4/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.35 |
| ▸ | SGK1 | O00141 | 4/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211895 | 0.92 | CNR1 (0.47) | CNR1PPARACFTRCNR2TYRO3 | |
| SCHEMBL212749 | 0.89 | MEN1 (0.41) | CNR1PPARACFTRCNR2 | |
| SCHEMBL213908 | 0.88 | NPY2R (0.37) | CNR1PPARACFTRCNR2GPR119 | |
| SCHEMBL14856883 | 0.88 | GPR119 (0.35) | CNR1PPARASGK1GPR119CYP17A1 | |
| SCHEMBL213232 | 0.87 | CNR1 (0.49) | CNR1CFTRCNR2HPGDS | |
| SCHEMBL213032 | 0.83 | CNR1 (0.44) | CNR1CFTRCNR2HPGDS | |
| SCHEMBL4058840 | 0.81 | KIF11 (0.41) | PPARASGK1CYP17A1KIF11PPARD | |
| SCHEMBL213341 | 0.81 | CNR1 (0.43) | CNR1CFTRCNR2HPGDS | |
| SCHEMBL212800 | 0.80 | CNR1 (0.51) | CNR1PPARACNR2 | |
| SCHEMBL14856733 | 0.80 | CNR1 (0.43) | CNR1PPARACNR2GPR119KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088920-B2 | 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents | HOFFMANN-LA ROCHE INC. (US) | 2012-01-03 | — | — | US | claimed |
| EP-2271632-A1 | 3-TRIFLUOROMETHYL-PYRAZINE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F. Hoffmann-La Roche AG (CH) | 2011-01-12 | — | — | EP | claimed |
| US-8088920-B2 | 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents | HOFFMANN-LA ROCHE INC. (US) | 2012-01-03 | — | — | US | disclosed |
| EP-2271632-A1 | 3-TRIFLUOROMETHYL-PYRAZINE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F. Hoffmann-La Roche AG (CH) | 2011-01-12 | — | — | EP | disclosed |